Veterinary Medicines

OLVAC A +B+MG Vaccino inattivato contro la Pseudopeste aviare, la Bronchite infettiva, la sindrome del calo di deposizione (EDS’76 ) e l’infezione da Mycoplasma gallisepticum

Authorised
  • Newcastle disease virus, Inactivated
  • Avian infectious bronchitis virus, Inactivated
  • Eggdrop syndrome-1976 virus, Inactivated
  • Mycoplasma gallisepticum, Inactivated
Download as PDF

Product identification

Medicine name:
OLVAC A +B+MG Vaccino inattivato contro la Pseudopeste aviare, la Bronchite infettiva, la sindrome del calo di deposizione (EDS’76 ) e l’infezione da Mycoplasma gallisepticum
Active substance:
  • Newcastle disease virus, Inactivated
  • Avian infectious bronchitis virus, Inactivated
  • Eggdrop syndrome-1976 virus, Inactivated
  • Mycoplasma gallisepticum, Inactivated
Target species:
  • Chicken (layer hen)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Newcastle disease virus, Inactivated
    50.00
    50% Protective Dose
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, Inactivated
    7.50
    log 10 50% embryo infective dose
    /
    1.00
    Dose
  • Eggdrop syndrome-1976 virus, Inactivated
    1000.00
    haemagglutinating units
    /
    1.00
    Dose
  • Mycoplasma gallisepticum, Inactivated
    30.00
    log10 colony forming unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Chicken (layer hen)
      • Egg
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AL
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 28/07/2022
Download